Common use of Authorization of Notes Clause in Contracts

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 aggregate principal amount of its 6.54% Senior Notes due March 15, 2010 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 50,000,000 aggregate principal amount of its 6.547.92% Senior Notes due March 15September 1, 2010 2006 (the "NotesNOTES", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 75,000,000 aggregate principal amount of its 6.546.39% Senior Notes due March October 15, 2010 2011 (the "NotesNOTES", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Section", "Schedule" or an "Exhibit" are, unless otherwise specified, to a Section of, or Schedule or an Exhibit attached to to, this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 75,000,000 aggregate principal amount of its 6.543.66% Series I Senior Notes due March 15May 17, 2010 2033 (as amended, amended and restated, supplemented or otherwise modified from time to time, the "“Notes"”, such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser and the Company. A. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 125,000,000 aggregate principal amount of its 6.547.31% Senior Notes due March 15April 30, 2010 2004 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of up to $60,000,000 7,000,000 aggregate principal amount of its 6.546% Senior Notes due March 15April 1, 2010 2012 (the "“Notes"”, such term to include any such notes issued in substitution therefor pursuant to Section 13 11 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 40,000,000 aggregate principal amount of its 6.546.44% Senior Notes due March July 15, 2010 2005 (the "Notes", ," such term to include any such notes issued in substitution therefor pursuant to Section SECTION 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit EXHIBIT 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule SCHEDULE B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 35,000,000 aggregate principal amount of its 6.547.12% Senior Notes due March 15November 1, 2010 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 9,000,000 aggregate principal amount of its 6.54% Floating Rate Senior Secured Notes due March 15December 28, 2010 2001 (the "NotesNOTES", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 75,000,000 aggregate principal amount of its 6.546.77% Senior Notes due March 15June 1, 2010 2009 (the "NotesNOTES", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 500,000,000 aggregate principal amount of its 6.546.32% Senior Notes due March 15, 2010 2004 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)13). The Notes shall be substantially in the form set out in Exhibit 1, with 1,with such changes therefrom, if any, as may be approved by each Purchaser and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 75,000,000 aggregate principal amount of its 6.546.96% Senior Notes due March 15May 1, 2010 2013 (the "Notes", ," such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 25,000,000 aggregate principal amount of its 6.546.55% Senior Notes due March April 15, 2010 2013 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 50,000,000 aggregate principal amount of its 6.545.46% Guaranteed Senior Notes Notes, due March 15April 29, 2010 2020 (the "“Notes", ,” such term to shall also include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)13). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser the Purchasers and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize has authorized the issue and sale of $60,000,000 40,000,000 aggregate principal amount of its 6.547.71% Senior Notes due March 1531, 2010 2007 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 30,000,000 aggregate principal amount of its 6.548.12% Senior Notes due March 15September 16, 2010 2009 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize has authorized the issue and sale of $60,000,000 100,000,000 aggregate principal amount of its 6.547.687% Senior Notes due March 15September 12, 2010 (the "“Notes"”, such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 27,500,000 aggregate principal amount of its 6.543.78% Senior Notes Notes, Series 2020A, due March September 15, 2010 2040 (each, as amended, restated or otherwise modified from time to time pursuant to Section 17, are collectively referred to as the "“Notes"”), such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)13). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 125,000,000 aggregate principal amount of its 6.545.47% Senior Notes Notes, Series 2022C, due March 15October 24, 2010 2052 (the "“Notes", ” such term to shall also include any such notes Notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 135,000,000 aggregate principal amount of its 6.544.87% Senior Notes due March 15July 31, 2010 2023 (the "Notes", ; such term to shall also include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)Agreement). The Notes shall be substantially in the form forms set out in Exhibit 1, 1 with such changes therefrom, if any, as may be approved by each Purchaser the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 aggregate 50,000,000 aggre- gate principal amount of its 6.547% Senior Notes due March 15February 1, 2010 2026 (the "‘‘Notes"’’, such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "‘‘Schedule" ’’ or an "‘‘Exhibit" ’’ are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 30,000,000 aggregate principal amount of its 6.548.50% Senior Secured Notes due March 15, 2010 2006 (the "NotesNOTES", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. The Notes will be secured by the Collateral, all as provided in the Security Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 50,000,000 aggregate principal amount of its 6.546.31% Senior Guaranteed Notes due March 15July 30, 2010 2006 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 175,000,000 aggregate principal amount of its 6.545.38% Senior Notes due March 15January 31, 2010 2015 (the "Notes", such ). The term to "Notes" shall also include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined))Agreement. The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 60,000,000.00 aggregate principal amount of its 6.546.93% Senior Notes due March 15June 9, 2010 2008 (the "“Notes"”, such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 75,000,000 aggregate principal amount of its 6.546.81% Senior Notes due March 1531, 2010 2007 (the "Notes", ," such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 275,000,000 aggregate principal amount of its 6.54% Class D Senior Notes due March 15(as they may from time to time be amended or supplemented, 2010 (the "“Notes", ,” such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)SECTION 14). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. The obligations of the Company under the Notes and this Agreement will be guaranteed by the Trust pursuant to SECTION 13.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 50,000,000 aggregate principal amount of its 6.545.62% Senior Notes due March 15January 20, 2010 2004 (the "“Notes"”, such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 40,000,000 aggregate principal amount of its 6.547.11% Senior Notes due March 15April 1, 2010 2012 (the "NotesNOTES", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "ScheduleSCHEDULE" or an "ExhibitEXHIBIT" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 125,000,000 aggregate principal amount of its 6.543.63% Senior Notes due March 15June 21, 2010 2046 (the "“Notes", such ,” the term to Notes shall also include any such notes issued in substitution therefor for the Notes pursuant to Section 13 of this Agreement (as hereinafter defined)Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser the Purchasers and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 100,000,000 aggregate principal amount of its 6.544.50% Series G Senior Notes due March 15February 16, 2010 2032 (as amended, amended and restated, supplemented or otherwise modified from time to time, the "“Notes"”, such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser and the Company. A. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 300,000,000 aggregate principal amount of its 6.544.66% Senior Guaranteed Notes due March 155, 2010 2011 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 150,000,000 aggregate principal amount of its 6.545.83% Senior Notes due March 15May 9, 2010 2007 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 25,000,000 aggregate principal amount of its 6.546.92% Senior Notes due March 15September 30, 2010 2004 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. .

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 35,000,000 aggregate principal amount of its 6.547.95% Senior Notes due March 15December 31, 2010 2003 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 45,000,000 aggregate principal amount of its 6.546.99% Senior Secured Notes due March 15, 2010 2009 (the "NotesNOTES", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize has authorized the issue and sale of $60,000,000 70,000,000 aggregate principal amount of its 6.549.49% Senior Notes due March 15April 1, 2010 2006 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize has authorized the issue and sale of $60,000,000 125,000,000 aggregate principal amount of its 6.544.22% Senior Notes Notes, due March August 15, 2010 2028 (the "“Notes"”, such term to include any such notes Notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser such Purchasers of such Notes and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 100,000,000 aggregate principal amount of its 6.546.72% Senior Notes due March 15September 8, 2010 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section toSection 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 £57,000,000 aggregate principal amount of its 6.547.78% Series I Senior Guaranteed Notes due March 15July 31, 2010 2018 (the "“Notes"”, such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)14). The Notes issued on Closing shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a "“Schedule" ” or an "“Exhibit" ” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 250,000,000 aggregate principal amount of its 6.546.25% Senior Notes due March 15April 11, 2010 2016 (the "NotesNOTES", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement or the Other Agreements (as hereinafter defined)). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by each Purchaser you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $60,000,000 175,000,000 aggregate principal amount of its 6.549% Senior Series A Notes due March 15, 2010 2032 (the "Notes", such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement (as hereinafter defined)the Indenture). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, A to the First Supplemental Indenture attached hereto as may be approved by each Purchaser and the Company. Exhibit A. Certain capitalized terms used in this Agreement are defined in Schedule BExhibit C; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.